XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses        
Research and development expenses $ 3,165 $ 2,063 $ 8,186 $ 7,800
General and administrative expenses 1,024 1,063 3,987 2,598
Marketing expenses 120 125 430 295
Total operating expenses 4,309 3,251 12,603 10,693
Operating loss 4,309 3,251 12,603 10,693
Other (income) expense        
Change in fair value of derivative liabilities 3,269
Other (income) expense, net (136) (12) (44) (12)
Finance income, net (2) 1,848 (68) 1,822
Net Loss 4,171 5,087 15,760 12,503
Other comprehensive income:        
Foreign currency translation adjustment (8) 17 (73) 11
Comprehensive loss for the period $ 4,163 $ 5,104 $ 15,687 $ 12,514
Basic net loss per share $ 4.64 $ 1,092 $ 30.09 $ 2,868
Diluted net loss per share $ 4.64 $ 1,092 $ 30.09 $ 2,868
Weighted-average shares used to compute basic net loss per share 899,410 4,663 523,833 4,464
Weighted-average shares used to compute diluted net loss per share 899,410 4,663 523,833 4,464